- Home
- EXEL vs DTM Comparison
EXEL vs DTM Comparison
Compare EXEL & DTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- DTM
- Stock Information
- Founded
- EXEL 1994
- DTM 2021
- Country
- EXEL United States
- DTM United States
- Employees
- EXEL N/A
- DTM N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- DTM Oil & Gas Production
- Sector
- EXEL Health Care
- DTM Utilities
- Exchange
- EXEL Nasdaq
- DTM Nasdaq
- Market Cap
- EXEL 10.4B
- DTM 11.1B
- IPO Year
- EXEL 2000
- DTM N/A
- Fundamental
- Price
- EXEL $38.94
- DTM $109.68
- Analyst Decision
- EXEL Buy
- DTM Buy
- Analyst Count
- EXEL 22
- DTM 12
- Target Price
- EXEL $44.10
- DTM $112.67
- AVG Volume (30 Days)
- EXEL 2.9M
- DTM 850.4K
- Earning Date
- EXEL 11-04-2025
- DTM 10-30-2025
- Dividend Yield
- EXEL N/A
- DTM 2.99%
- EPS Growth
- EXEL 81.76
- DTM N/A
- EPS
- EXEL 2.08
- DTM 3.96
- Revenue
- EXEL $2,230,005,000.00
- DTM $1,175,000,000.00
- Revenue This Year
- EXEL $9.14
- DTM $26.71
- Revenue Next Year
- EXEL $12.59
- DTM $8.53
- P/E Ratio
- EXEL $18.75
- DTM $27.70
- Revenue Growth
- EXEL 10.73
- DTM 20.39
- 52 Week Low
- EXEL $31.18
- DTM $83.30
- 52 Week High
- EXEL $49.62
- DTM $115.80
- Technical
- Relative Strength Index (RSI)
- EXEL 50.54
- DTM 52.92
- Support Level
- EXEL $33.76
- DTM $104.99
- Resistance Level
- EXEL $40.63
- DTM $107.54
- Average True Range (ATR)
- EXEL 1.30
- DTM 2.73
- MACD
- EXEL 0.17
- DTM -0.42
- Stochastic Oscillator
- EXEL 75.47
- DTM 59.14
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About DTM DT Midstream Inc.
DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.